Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old
Yanfeng Liu(First Affiliated Hospital of Xi'an Jiaotong University), Mei Zhang(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 9
Related Papers
miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation
|Cell Death and Disease|2017|174
TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling
|Yonsei Medical Journal|2017|29